Eisai EMEA - Case Discussions: In the current MBC treatment landscape of HR+/HER2- and TNBC, what’s the role of chemotherapy? (ID 47)

Clinical Case in HR+/HER2- discussion (ID 466)

Lecture Time
12:50 - 13:05
Speakers
  • Frederik Marmé (Mannheim, Germany)
Authors
  • Frederik Marmé (Mannheim, Germany)
Session Name
Eisai EMEA - Case Discussions: In the current MBC treatment landscape of HR+/HER2- and TNBC, what’s the role of chemotherapy? (ID 47)
Room
Frankfurt Hall
Date
Thu, 05.05.2022
Time
12:30 - 13:30